A Bermudian genetics firm has gained top marks at the MedTech Investing Europe Forum in London, winning the event’s Best in Show award.

CariGenetics took part in the event, organised by Campden Wealth, last week, which brought together companies with potential investors.

The firm said: “The event featured 26 medical technology companies pitching investment opportunities to an audience of 100 delegates, including family offices, private wealth holders, venture capitalists, corporations and angel investors.

“The forum programme addressed major challenges and opportunities in healthcare, life sciences, AI and digital health investment.”

Carika Weldon, a geneticist and the company’s founder and chief executive, highlighted CariGenetics as the “Caribbean real-world evidence and engagement platform.

Dr Weldon said: “Our platform is pivotal in advancing healthcare research, expanding therapeutic access and improving patient care in the Caribbean.

“Winning this competition highlights the importance of our work while solidifying our company as a viable investment opportunity from a global lens.”

Kevin Grant, the executive director of Campden Wealth, said: “The standard of technology and innovation on show at the 34th MedTech Investing Forum in London last week was breathtaking and augmented by the compelling plenary sessions from the NHS and Industry.

“CariGenetics were a worthy winner of the ‘Best in Show’ award and highlighted the cutting- edge innovation that is being developed in Bermuda.”

Kevin Richards, managing director of Bermuda Asset Management and a member of the CariGenetics Business Development Advisory Board, added: “Representing Bermuda at such a prestigious event underscores our commitment to bringing world-class research and innovation to the Caribbean.

“Our participation and success at the MTI Europe Forum demonstrate our capability and vision to make a global impact.”